Given the dependence on CD8 T cells for tumor control (Supplementary Figure S3), our data overall suggest that neoantigen vaccination induces specific CD4 T cells, and expands, and broadens the tumor-directed T cell response including neoantigen-specific CD8 T cells. This evidence concerns the gene CD8A and neoplasm.